An Editorial by Dr. Cathy Knupp, Executive Vice President and President, Research and Development, Zoetis
New infectious diseases and new subtypes of ever-present diseases are constantly emerging. These diseases can affect animals and people alike. Zoetis is at the forefront of the battle to combat bacteria and viruses threatening animal health.
The Zoetis for Shelters program provides exceptional discounts on many of the Zoetis products that shelters use most. The average shelter saves $4,592 a year. This money saved can instead go towards helping more pets find forever homes.
Today, Zoetis was named one of America’s Best Midsize Employers in 2016 by Forbes Magazine. Zoetis is the only pharmaceutical company focused solely on animal health to make the list, and is ranked #81 out of 250 midsize companies.
Kristin Peck, Executive Vice President and President, U.S. Operations, shares her insights on the importance of antibiotic stewardship.
Karen Stasiak, Area Veterinarian for Zoetis, volunteers each year for the annual Can-AM Crown Sled Dog Race.
The U.S. Food and Drug Administration (FDA) has approved Simparica™, a once-monthly chewable flea and tick medication for dogs.
Clinton Lewis, executive vice president and president, International Operations at Zoetis, has been recognized by Savoy magazine as one of 2016’s Top 100 Most Influential African-Americans in Corporate America. He joins some of the nation’s most seasoned executives and business leaders, who were honored based on exemplary accomplishments and influence.
Heidi Chen, General Counsel for Zoetis, was recently presented with the 2016 Justice in Action Award by the Asian American Legal Defense Fund, which recognizes outstanding achievements and efforts in advancing social justice in the U.S. Below is an adaptation of Heidi’s remarks from the event.
Julie Carlson was named winner of the 2015 American Humane Association Hero Veterinary Technician Award because of her extraordinary work on behalf of animals and military veterans.
Dr. Scott A. Brown, Vice President of External Innovation, Veterinary Medicine Research & Development at Zoetis, shares Zoetis' approach to research alliances with organizations and companies across the pharmaceutical, biotechnology, agribusiness and animal health industries and describes the company’s research areas of interest.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.